469 related articles for article (PubMed ID: 22108454)
1. The epidemiology of community-acquired Clostridium difficile infection: a population-based study.
Khanna S; Pardi DS; Aronson SL; Kammer PP; Orenstein R; St Sauver JL; Harmsen WS; Zinsmeister AR
Am J Gastroenterol; 2012 Jan; 107(1):89-95. PubMed ID: 22108454
[TBL] [Abstract][Full Text] [Related]
2. Outcomes in community-acquired Clostridium difficile infection.
Khanna S; Pardi DS; Aronson SL; Kammer PP; Baddour LM
Aliment Pharmacol Ther; 2012 Mar; 35(5):613-8. PubMed ID: 22229532
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of Clostridium difficile infection in children: a population-based study.
Khanna S; Baddour LM; Huskins WC; Kammer PP; Faubion WA; Zinsmeister AR; Harmsen WS; Pardi DS
Clin Infect Dis; 2013 May; 56(10):1401-6. PubMed ID: 23408679
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
[TBL] [Abstract][Full Text] [Related]
5. Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions.
Lambert PJ; Dyck M; Thompson LH; Hammond GW
Infect Control Hosp Epidemiol; 2009 Oct; 30(10):945-51. PubMed ID: 19732008
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of community-associated Clostridium difficile infection.
Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
[TBL] [Abstract][Full Text] [Related]
7. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
Khanna S; Aronson SL; Kammer PP; Baddour LM; Pardi DS
Mayo Clin Proc; 2012 Jul; 87(7):636-42. PubMed ID: 22766083
[TBL] [Abstract][Full Text] [Related]
8. A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.
Crews JD; Koo HL; Jiang ZD; Starke JR; DuPont HL
Pediatr Infect Dis J; 2014 Sep; 33(9):924-8. PubMed ID: 25361022
[TBL] [Abstract][Full Text] [Related]
9. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.
Kuntz JL; Chrischilles EA; Pendergast JF; Herwaldt LA; Polgreen PM
BMC Infect Dis; 2011 Jul; 11():194. PubMed ID: 21762504
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC
BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections.
Taori SK; Wroe A; Hardie A; Gibb AP; Poxton IR
J Infect; 2014 Aug; 69(2):134-44. PubMed ID: 24780765
[TBL] [Abstract][Full Text] [Related]
12. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?
Dubberke ER; McMullen KM; Mayfield JL; Reske KA; Georgantopoulos P; Warren DK; Fraser VJ
Infect Control Hosp Epidemiol; 2009 Apr; 30(4):332-7. PubMed ID: 19239377
[TBL] [Abstract][Full Text] [Related]
13. Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus.
Clohessy P; Merif J; Post JJ
Int J Infect Dis; 2014 Dec; 29():152-5. PubMed ID: 25449250
[TBL] [Abstract][Full Text] [Related]
14. Assessment of administrative data for evaluating the shifting acquisition of Clostridium difficile infection in England.
Jen MH; Saxena S; Bottle A; Pollok R; Holmes A; Aylin P
J Hosp Infect; 2012 Mar; 80(3):229-37. PubMed ID: 22306443
[TBL] [Abstract][Full Text] [Related]
15. Multicenter study of Clostridium difficile infection rates from 2000 to 2006.
Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799
[TBL] [Abstract][Full Text] [Related]
16. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
Suárez-Bode L; Barrón R; Pérez JL; Mena A
Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
[TBL] [Abstract][Full Text] [Related]
17. Community-acquired Clostridium difficile infection in children: A retrospective study.
Borali E; Ortisi G; Moretti C; Stacul EF; Lipreri R; Gesu GP; De Giacomo C
Dig Liver Dis; 2015 Oct; 47(10):842-6. PubMed ID: 26141927
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile infection in the community: are proton pump inhibitors to blame?
Freedberg DE; Abrams JA
World J Gastroenterol; 2013 Oct; 19(40):6710-3. PubMed ID: 24187445
[TBL] [Abstract][Full Text] [Related]
19. Clostridioides difficile infection-associated cause-specific and all-cause mortality: a population-based cohort study.
Boven A; Vlieghe E; Engstrand L; Andersson FL; Callens S; Simin J; Brusselaers N
Clin Microbiol Infect; 2023 Nov; 29(11):1424-1430. PubMed ID: 37473840
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of community-associated Clostridium difficile infection in Kuwait: Epidemiology and ribotypes.
Jamal W; Pauline E; Rotimi V
Anaerobe; 2015 Oct; 35(Pt B):28-32. PubMed ID: 26144314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
